Evaluating the Safety of and Immune Response to an HIV Vaccine Followed by Booster, Administered by Two Devices, in HIV-Uninfected Adults

NCT01260727 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

92

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

BIOLOGICAL: PENNVAX-G DNA Vaccine
BIOLOGICAL: MVA-CMDR Vaccine
BIOLOGICAL: Placebo PENNVAX-G Vaccine
BIOLOGICAL: Placebo MVA-CMDR Vaccine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)